Stereotactic radiosurgery for multiple brain metastases

References

• Langer CJ, Mehta MP. Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005;23(25):6207-19
   PubMed Web of Science ®Google Scholar
• Smedby KE, Brandt L, Backlund ML, Blomqvist P. Brain. metastases admissions in Sweden between. 1987 and 2006. Br J Cancer 2009;101(11):1919-24
   PubMed Web of Science ®Google Scholar
• Tabouret E, Chinot O, Metellus P, et al. Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 2012;32(11):4655-62
   PubMed Web of Science ®Google Scholar
• Nieder C, Spanne O, Mehta MP, et al. Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer 2011;117(11):2505-12
   PubMed Web of Science ®Google Scholar
• Langley RE, Stephens RJ, Nankivell M, et al. Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer? Clin Oncol (R Coll Radiol) 2013;25(3):e23-30
   PubMed Web of Science ®Google Scholar
• Halasz LM, Weeks JC, Neville BA, et al. Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys 2013;85(2):e109-16
   Google Scholar
• Sturm V, Kober B, Hover KH, et al. Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator. Int J Radiat Oncol Biol Phys 1987;13(2):279-82
   PubMed Web of Science ®Google Scholar
• Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999;45(2):427-34
   PubMed Web of Science ®Google Scholar
• Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004;363(9422):1665-72
   PubMed Web of Science ®Google Scholar
• Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006;295(21):2483-91
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009;10(11):1037-44
   PubMed Web of Science ®Google Scholar
• Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2011;29(2):134-41
   PubMed Web of Science ®Google Scholar
• Tsao MN, Rades D, Wirth A, et al. International practice survey on the management of brain metastases: third international consensus workshop on palliative radiotherapy and symptom control. Clin Oncol (R Coll Radiol) 2012;24(6):e81-92
   Google Scholar
• Knisely JP, Yamamoto M, Gross CP, et al. Radiosurgery alone for 5 or more brain metastases: expert opinion survey. J Neurosurg 2010;113(Suppl):84-9
   PubMedGoogle Scholar
• Aoyama H, Tago M, Kato N, et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 2007;68(5):1388-95
   PubMed Web of Science ®Google Scholar
• Soffietti R, Kocher M, Abacioglu UM, et al. A European organisation for research and treatment of cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 2013;31(1):65-72
   PubMed Web of Science ®Google Scholar
• Soltys SG, Adler JR, Lipani JD, et al. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 2008;70(1):187-93
   PubMed Web of Science ®Google Scholar
• Kellogg R, Straus D, Choi M, et al. Stereotactic radiosurgery boost to the resection cavity for cerebral metastases: report of overall survival, complications, and corticosteroid protocol. Surg Neurol Int 2013;4(Suppl 6):S436-42
   Google Scholar
• Mahajan A. Resection Bed Post-Surgical Stereotactic Radiosurgery (SRS). Available from: http://clinicaltrials.gov/show/NCT00950001
   Google Scholar
• Brown PD. Stereotactic radiosurgery or whole-brain radiation therapy in treating patients with brain metastases that have been removed by surgery. Available from: http://clinicaltrials.gov/show/NCT01372774
   Google Scholar
• Sahgal A; ASTRO. Adult cancer patients younger than 50 presenting with a limited number of brain metastases have improved overall survival after stereotactic radiosurgery alone. 2013. Available from: https://www.astro.org/news-and-media/news-releases/2013/adult-cancer-patients-younger-than-50-presenting.aspx
   Google Scholar
• Lester SC, Taksler GB, Kuremsky JG, et al. Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer 2014;120(3):433-41
   Google Scholar
• Tsao MN, Rades D, Wirth A, et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2012;2(3):210-25
   PubMedGoogle Scholar
• NCCN Clinical Practice Guidelines in Oncology. Central Nervous System Cancers. 2013. Available from: http://www.nccn.org/network/business_insights/flash_updates/flash_update_information.asp?FlashID=5
   Google Scholar
• Soffietti R, Cornu P, Delattre JY, et al. Brain. metastases. In: European handbook of neurological management. Wiley-Blackwell, Hoboken, NJ, USA; 2010. p. 437-45
   Google Scholar
• Tsao MN, Lloyd N, Wong RK, et al. Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases. Cochrane Database Syst Rev 2012;4:Cd003869
   PubMed Web of Science ®Google Scholar
• Nieder C, Andratschke N, Grosu AL, Molls M. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Strahlenther Onkol 2003;179(1):16-20
   Google Scholar
• Terahara A, Machida T, Kubo T, et al. Analysis of dose distribution in gamma knife radiosurgery for multiple targets. Int J Radiat Oncol Biol Phys 2000;47(5):1431-4
   Google Scholar
• Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 2014;15(4):387-95
   PubMed Web of Science ®Google Scholar
• Gonda DD, Kim TE, Goetsch SJ, et al. Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration. Eur J Cancer (Oxford, England : 1990) 2014;50(6):1148-58
   Google Scholar
• Vern-Gross TZ, Lawrence JA, Case LD, et al. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol 2012;110(3):381-8
   PubMed Web of Science ®Google Scholar
• Tam M, Narayana A, Raza S, et al. Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery. Med Oncol 2014;31(2):832
   Google Scholar
• Kuremsky JG, Urbanic JJ, Petty WJ, et al. Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery 2013;73(4):641-7. discussion 647
   Google Scholar
• Grandhi R, Kondziolka D, Panczykowski D, et al. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases. J Neurosurg 2012;117(2):237-45
   Google Scholar
• Liew DN, Kano H, Kondziolka D, et al. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article. J Neurosurg 2011;114(3):769-79
   PubMed Web of Science ®Google Scholar
• Cochran DC, Chan MD, Aklilu M, et al. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg 2012;116(5):978-83
   PubMed Web of Science ®Google Scholar
• Seastone DJ, Elson P, Garcia JA, et al. Clinical outcome of stereotactic radiosurgery for central nervous system metastases from renal cell carcinoma. Clin Genitourin Cancer 2013;12(2):111-16
   Google Scholar
• Kim H, Jung TY, Kim IY, et al. The usefulness of stereotactic radiosurgery for radioresistant brain metastases. J Korean Neurosurg Soc 2013;54(2):107-11
   Google Scholar
• Douglas JG, Margolin K. The treatment of brain metastases from malignant melanoma. Semin Oncol 2002;29(5):518-24
   PubMedGoogle Scholar
• Hauswald H, Dittmar JO, Habermehl D, et al. Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma. Radiat Oncol 2012;7:130
   PubMed Web of Science ®Google Scholar
• Oermann EK, Kress MA, Todd JV, et al. The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases. J Neurosurg 2013;119(5):1131-8
   Google Scholar
• Kim DH, Schultheiss TE, Radany EH, et al. Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery. J Neurooncol 2013;115(1):37-43
   Google Scholar
• Nath SK, Lawson JD, Simpson DR, et al. Single-isocenter frameless intensity-modulated stereotactic radiosurgery for simultaneous treatment of multiple brain metastases: clinical experience. Int J Radiat Oncol Biol Phys 2010;78(1):91-7
   Google Scholar
• Ma L, Sahgal A, Hwang A, et al. A two-step optimization method for improving multiple brain lesion treatments with robotic radiosurgery. Technol Cancer Res Treat 2011;10(4):331-8
   Google Scholar
• Ma L, Petti P, Wang B, et al. Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple brain metastases. J Neurosurg 2011;114(6):1580-4
   PubMed Web of Science ®Google Scholar
• Sahgal A, Barani IJ, Novotny J Jr, et al. Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010;78(2):605-8
   Google Scholar
• Korytko T, Radivoyevitch T, Colussi V, et al. 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys 2006;64(2):419-24
   PubMed Web of Science ®Google Scholar
• Lal LS, Byfield SD, Chang EL, et al. Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radiation therapy in patients with 1 to 3 brain metastases. Am J Clin Oncol 2012;35(1):45-50
   PubMed Web of Science ®Google Scholar
• Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000;20(3):332-42
   PubMed Web of Science ®Google Scholar
• Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146(4):473-81
   PubMed Web of Science ®Google Scholar
• Culyer A, Mccabe C, Briggs A, et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy 2007;12(1):56-8
   PubMedGoogle Scholar
• Lee WY, Cho DY, Lee HC, et al. Outcomes and cost-effectiveness of gamma knife radiosurgery and whole brain radiotherapy for multiple metastatic brain tumors. J Clin Neurosci 2009;16:640-34
   Google Scholar
• Vuong DA, Rades D, Van Eck AT, et al. Comparing the cost-effectiveness of two brain metastasis treatment modalities from a payer’s perspective: stereotactic radiosurgery versus surgical resection. Clin Neurol Neurosurg 2013;115(3):276-84
   Google Scholar
• Brown PD. Phase III Randomized trial of the role of whole brain radiation therapy in addition to radiosurgery in patients with one to three cerebral metastases. Available from: http://clinicaltrials.gov/show/NCT00377156
   Google Scholar
• Stereotactic radiation therapy with or without whole-brain radiation therapy in treating patients with brain metastases. Available from: www.clinicaltrials.gov/ct2/results?term=NCT00377156&Search=Search
   Google Scholar
• Barani IJ. A randomized controlled study of neurocognitive outcomes in patients with five or more brain metastases treated with radiosurgery or whole-brain radiotherapy (NAGKC 12-01). Available from: http://clinicaltrials.gov/show/NCT01731704
   Google Scholar
• Barani IJ. Multi-institution, non-randomized trial of neurocognitive outcomes in patients with multiple, newly-diagnosed brain metastases managed primarily with the gamma knife (GK) radiosurgery system. Available from: http://clinicaltrials.gov/ct2/show/NCT01821443
   Google Scholar
• Sulman EP. A prospective randomized Phase III trial to compare local control and neurocognitive preservation after initial treatment with stereotactic radiosurgery (SRS) versus whole brain radiation therapy (WBRT) for patients with >3 brain metastases from melanoma. Available from: http://clinicaltrials.gov/show/NCT01644591
   Google Scholar
• Li J. A prospective Phase III randomized trial to compare stereotactic radiosurgery versus whole brain radiation therapy for ≥ 4 newly diagnosed non-melanoma brain metastases. Available from: http://clinicaltrials.gov/show/NCT01592968
   Google Scholar
• Lin NU. Targeted therapies in brain metastases. Curr Treat Options Neurol 2014;16(1):276
   PubMed Web of Science ®Google Scholar
• Barani IJ, Larson DA, Berger MS. Future directions in treatment of brain metastases. Surg Neurol Int 2013;4(Suppl 4):S220-30
   PubMedGoogle Scholar
• Suzuki S, Omagari J, Nishio S, et al. Gamma knife radiosurgery for simultaneous multiple metastatic brain tumors. J Neurosurg 2000;93(Suppl 3):30-1
   Google Scholar
• Amendola BE, Wolf A, Coy S, Amendola MA. Radiosurgery as palliation for brain metastases: a retrospective review of 72 patients harboring multiple lesions at presentation. J Neurosurg 2002;97(Suppl 5):511-14
   PubMedGoogle Scholar
• Jawahar A, Shaya M, Campbell P, et al. Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases. Surg Neurol 2005;64(3):207-12
   Google Scholar
• Nam TK, Lee JI, Jung YJ, et al. Gamma knife surgery for brain metastases in patients harboring four or more lesions: survival and prognostic factors. J Neurosurg 2005;102(Suppl):147-50
   Google Scholar
• Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic radiosurgery for four or more intracranial metastases. Int J Radiat Oncol Biol Phys 2006;64(3):898-903
   PubMed Web of Science ®Google Scholar
• Kim CH, Im YS, Nam DH, et al. Gamma knife radiosurgery for ten or more brain metastases. J Korean Neurosurg Soc 2008;44(6):358-63
   Google Scholar
• Karlsson B, Hanssens P, Wolff R, et al. Thirty years’ experience with Gamma Knife surgery for metastases to the brain. J Neurosurg 2009;111(3):449-57
   Google Scholar
• Chang WS, Kim HY, Chang JW, et al. Analysis of radiosurgical results in patients with brain metastases according to the number of brain lesions: is stereotactic radiosurgery effective for multiple brain metastases? J Neurosurg 2010;113:73-8
   PubMed Web of Science ®Google Scholar
• Serizawa T, Hirai T, Nagano O, et al. Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol 2010;98(2):163-7
   Google Scholar
• Caballero JA, Sneed PK, Lamborn KR, et al. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy. Int J Radiat Oncol Biol Phys 2012;83(1):303-9
   PubMed Web of Science ®Google Scholar
• Hunter GK, Suh JH, Reuther AM, et al. Treatment of five or more brain metastases with stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2012;83(5):1394-8
   PubMed Web of Science ®Google Scholar
• Maranzano E, Trippa F, Casale M, et al. Reirradiation of brain metastases with radiosurgery. Radiother Oncol 2012;102(2):192-7
   Google Scholar
• Mohammadi AM, Recinos PF, Barnett GH, et al. Role of Gamma Knife surgery in patients with 5 or more brain metastases. J Neurosurg 2012;117(Suppl):5-12
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Sato Y, Serizawa T, et al. Subclassification of recursive partitioning analysis Class II patients with brain metastases treated radiosurgically. Int J Radiat Oncol Biol Phys 2012;83(5):1399-405
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Kawabe T, Sato Y, et al. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article. J Neurosurg 2013;118(6):1258-68
   Google Scholar
• Baschnagel AM, Meyer KD, Chen PY, et al. Tumor volume as a predictor of survival and local control in patients with brain metastases treated with gamma knife surgery. J Neurosurg 2013;119(5):1139-44
   Google Scholar
• Likhacheva A, Pinnix CC, Parikh NR, et al. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2013;85(3):656-61
   Google Scholar
• Minniti G, Esposito V, Clarke E, et al. Stereotactic radiosurgery in elderly patients with brain metastases. J Neurooncol 2013;111(3):319-25
   Google Scholar
• Raldow AC, Chiang VL, Knisely JP, Yu JB. Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery. Am J Clin Oncol 2013;36(5):486-90
   Google Scholar
• Rava P, Leonard K, Sioshansi S, et al. Survival among patients with 10 or more brain metastases treated with stereotactic radiosurgery. J Neurosurg 2013;119(2):457-62
   Google Scholar
• Salvetti DJ, Nagaraja TG, Mcneill IT, et al. Gamma Knife surgery for the treatment of 5 to 15 metastases to the brain: clinical article. J Neurosurg 2013;118(6):1250-7
   Google Scholar
• Yomo S, Hayashi M. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases. J Neurooncol 2013;113(3):459-65
   Google Scholar
• Kurtz G, Zadeh G, Gingras-Hill G, et al. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection. Int J Radiat Oncol Biol Phys 2014;88(1):137-42
   Google Scholar
• Amendola BE, Wolf AL, Coy SR, et al. Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast. Cancer J Sudbury, Mass 2000;6(2):88-92
   PubMed Web of Science ®Google Scholar
• Matsunaga S, Shuto T, Kawahara N, et al. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype. J Neurosurg 2010;113:65-72
   Google Scholar
• Kondziolka D, Kano H, Harrison GL, et al. Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer. Clinical article. J Neurosurg 2011;114(3):792-800
   Google Scholar
• Choi SW, Kwon Do H, Kim CJ. Clinical outcome in gamma knife radiosurgery for metastatic brain tumors from the primary breast cancer : prognostic factors in local treatment failure and survival. J Korean Neurosurg Soc 2013;54(4):329-35
   Google Scholar
• Serizawa T, Iuchi T, Ono J, et al. Gamma knife treatment for multiple metastatic brain tumors compared with whole-brain radiation therapy. J Neurosurg 2000;93(Suppl 3):32-6
   PubMedGoogle Scholar
• Wegner RE, Olson AC, Kondziolka D, et al. Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer. Int J Radiat Oncol Biol Phys 2011;81(3):e21-7
   Google Scholar